Evidence map›Paper›PMID 41143151›Full record

ReviewFrontiers in human neuroscience2025

A summary of the current circumstances of migraineurs in China: a review of the GBD2019 database.

Changchang Ying, Qijun Yu, Qingling Zhai, Yonghui Pan

Abstract readReview
In one paragraph

Review in Frontiers in human neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Changchang YingDepartment of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Qijun YuDepartment of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Qingling ZhaiDepartment of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Yonghui PanDepartment of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Migraine is a common, chronic and recurrent neurovascular disorder ranked by the WHO as one of the 20 most disabling conditions worldwide. Frequent and severe headaches can significantly impair patients' quality of life, learning capacity, and physical and mental health. On the basis of the Global Burden of Disease (GBD) 2019 database, this article reviews the incidence, disability and treatment of migraine in China in recent years. This study aims to analyze the current status of migraine patients in China and to inform future research on its epidemiology, prevention, and treatment.

Indexed as

Chinadisabilityincidencemigrainetreatment

Identifiers

PMID41143151
PMCPMC12549686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.